DTB select: Bisphosphonates and atypical fractures

Summary and context is provided on a cohort study which found that long-term use of bisphosphonates was associated with an increased risk of atypical femoral fractures but that this was largely outweighed by the reduction in the risk of other fractures.

Source:

Drug and Therapeutics Bulletin